LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial
The therapeutic landscape for mental health is undergoing a significant shift as researchers revisit substances once relegated to the fringes of medicine. A recent pilot study conducted by researchers at…







